FT. LAUDERDALE, Fla.,
March 1, 2017 /PRNewswire/
-- DuPont Executive Vice President James C. Collins discussed
priorities for the company's agriculture business segment today at
the Bank of America Merrill Lynch 2017 Global Agriculture and
Chemicals Conference, including plans to deliver new genetics,
biotech traits and crop protection products.
"As demand for grain and other food products continues to
increase, the most urgent challenge for growers is to improve crop
productivity on every acre," Collins said. "As a result of our
ongoing strategic investments in agriculture research, DuPont has
the tools to help growers produce more crops on each acre, which
drives value for our customers and our shareholders.
"Addressing these challenges creates attractive long-term growth
opportunities for DuPont," Collins said. "In 2017, we are focused
on achieving our financial commitments, and driving rapid and
successful technology launches."
Pipeline Delivers Near- and Long-Term Solutions
Collins presented an update of the agriculture research pipeline
for DuPont, including a 2017 limited commercial introduction of
Pioneer® brand Qrome™ products1.
He also highlighted launches of Pioneer® brand A-Series
soybeans and DuPont™ Vessarya™ disease
control, as well as regional expansions of Pioneer®
brand hybrids with Leptra® insect protection and
DuPont™ Zorvec™ fungicide.
"Our new corn hybrids and soybean varieties are delivering
outstanding performance, demonstrating the benefits of the focused
investments we have made in recent years," said Collins. "We have
created one of the most extensive germplasm libraries in the world
and continue to advance our expertise by encompassing
marker-assisted selection, trait integration, and the latest in
targeted breeding techniques."
Qrome™ products unlock more of the full performance
potential of Pioneer's elite corn germplasm. These
high-yielding Qrome™ products feature an advanced,
proprietary molecular stack trait technology to provide yield
protection against above- and below-ground pests. In multi-year
testing, Qrome™ products consistently delivered 4-7
bushels per acre yield improvement over legacy
technologies.1
In Brazil, Leptra®
insect protection offers broad-spectrum above-ground insect
control. The initial launch of Leptra® insect protection
in the 2016/2017 Brazil summer
season was one of the fastest technology ramp ups in Pioneer
history; Pioneer will continue its expansion of Leptra®
by launching the product in Argentina this year.
Collins said he expects Pioneer to continue as a market leader
in soybeans with the launch of the new A-Series soybeans, Pioneer's
highest yielding line of soybean varieties ever. In 2017,
Pioneer is offering 54 new A-Series varieties, including 30 new
varieties of Pioneer® brand soybeans with Roundup Ready
2 Xtend® technology. In 2016 on-farm Pioneer
trials, A-Series varieties produced an average yield advantage of
2.3 bu/acre against 10,000 comparisons of elite competitors at 400
locations.2
Collins discussed DuPont™ Zorvec™ disease control, which
delivers consistent and longer control of oomycete diseases such as
late blight and downy mildew for growers of potatoes, grapes and
vegetables. First sales of Zorvec™ disease control products were in
2016, and are now sold in more than 10 countries, including
China. Additional countries
in Asia Pacific and Latin America are expected to launch in
2017.
Another fungicide that is launching in Brazil this year, DuPont™
Vessarya™, combines two leading fungicides to provide
protection against Asian soybean rust. Testing has shown
Vessarya™ fungicide provided superior performing control of Asian
soybean rust, with highest average yield compared to competitive
treatments.3
Collins also highlighted DuPont's research for insect control.
DuPont™ Pyraxalt™ insecticide, which has been specifically
developed to protect rice crops in Asia, is nearing launch with first sales
expected in 2018. With novel activity for control of a wide
spectrum of hopper insects in rice, Pyraxalt™ insecticide is
expected to set a new standard for high potency, low use rate with
a favorable environmental profile.
To view a full copy of today's presentation, visit the "Events
& Presentations" page on the DuPont Investor Center.
DuPont (NYSE: DD) has been bringing world-class science and
engineering to the global marketplace in the form of innovative
products, materials, and services since 1802. The company believes
that by collaborating with customers, governments, NGOs, and
thought leaders, we can help find solutions to such global
challenges as providing enough healthy food for people everywhere,
decreasing dependence on fossil fuels, and protecting life and the
environment. For additional information about DuPont and its
commitment to inclusive innovation, please visit
www.dupont.com.
Forward-Looking Statements:
This communication contains "forward-looking statements" within
the meaning of the federal securities laws, including Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. In this context,
forward-looking statements often address expected future business
and financial performance and financial condition, and often
contain words such as "expect," "anticipate," "intend," "plan,"
"believe," "seek," "see," "will," "would," "target," similar
expressions, and variations or negatives of these words.
Forward-looking statements by their nature address matters that
are, to different degrees, uncertain, such as statements about the
consummation of the proposed transaction and the anticipated
benefits thereof. Forward-looking statements are not guarantees of
future performance and are based on certain assumptions and
expectations of future events which may not be realized.
Forward-looking statements also involve risks and uncertainties,
many of which are beyond the company's control. Some of the
important factors that could cause the company's actual results to
differ materially from those projected in any such forward-looking
statements are: fluctuations in energy and raw material prices;
failure to develop and market new products and optimally manage
product life cycles; ability to respond to market acceptance,
rules, regulations and policies affecting products based on
biotechnology and, in general, for products for the agriculture
industry; outcome of significant litigation and environmental
matters, including realization of associated indemnification
assets, if any; failure to appropriately manage process safety and
product stewardship issues; changes in laws and regulations or
political conditions; global economic and capital markets
conditions, such as inflation, interest and currency exchange
rates; business or supply disruptions; security threats, such as
acts of sabotage, terrorism or war, natural disasters and weather
events and patterns which could affect demand as well as
availability of products for the agriculture industry; ability to
protect and enforce the company's intellectual property rights;
successful integration of acquired businesses and separation of
underperforming or non-strategic assets or businesses; and risks
related to the agreement entered on December
11, 2015, with The Dow Chemical Company pursuant to which
the companies have agreed to effect an all-stock merger of equals,
including the completion of the proposed transaction on anticipated
terms and timing, the ability to fully and timely realize the
expected benefits of the proposed transaction and risks related to
the intended business separations contemplated to occur after the
completion of the proposed transaction. Important risk factors
relating to the proposed transaction and intended business
separations include, but are not limited to, (i) the
completion of the proposed transaction on anticipated terms and
timing, including obtaining regulatory approvals, anticipated
tax treatment, unforeseen liabilities, future capital expenditures,
revenues, expenses, earnings, synergies, economic performance,
indebtedness, financial condition, losses, future prospects,
business and management strategies for the management, expansion
and growth of the new combined company's operations and other
conditions to the completion of the merger, (ii) the ability of Dow
and DuPont to integrate the business successfully and to achieve
anticipated synergies, risks and costs and pursuit and/or
implementation of the potential separations, including anticipated
timing, any changes to the configuration of businesses included in
the potential separation if implemented, (iii) the intended
separation of the agriculture, material science and specialty
products businesses of the combined company post-mergers in one or
more tax efficient transactions on anticipated terms and timing,
including a number of conditions which could delay, prevent or
otherwise adversely affect the proposed transactions, including
possible issues or delays in obtaining required regulatory
approvals or clearances, disruptions in the financial markets or
other potential barriers, (iv) potential litigation relating to the
proposed transaction that could be instituted against Dow, DuPont
or their respective directors, (v) the risk that disruptions from
the proposed transaction will harm Dow's or DuPont's business,
including current plans and operations, (vi) the ability of Dow or
DuPont to retain and hire key personnel, (vii) potential adverse
reactions or changes to business relationships resulting from the
announcement or completion of the merger, (viii) uncertainty as to
the long-term value of DowDuPont common stock, (ix) continued
availability of capital and financing and rating agency actions,
(x) legislative, regulatory and economic developments, (xi)
potential business uncertainty, including changes to existing
business relationships, during the pendency of the merger that
could affect Dow's and/or DuPont's financial performance, (xii)
certain restrictions during the pendency of the merger that may
impact Dow's or DuPont's ability to pursue certain business
opportunities or strategic transactions and (xiii) unpredictability
and severity of catastrophic events, including, but not limited to,
acts of terrorism or outbreak of war or hostilities, as well as
management's response to any of the aforementioned factors. These
risks, as well as other risks associated with the proposed merger,
are more fully discussed in the joint proxy statement/prospectus
included in the registration statement on Form S-4 declared
effective by the SEC on June 9, 2016
(File No. 333-209869), as last amended, (the "Registration
Statement") in connection with the proposed merger. While the list
of factors presented here is, and the list of factors presented in
the Registration Statement are, considered representative, no such
list should be considered to be a complete statement of all
potential risks and uncertainties. Unlisted factors may present
significant additional obstacles to the realization of
forward-looking statements. Consequences of material differences in
results as compared with those anticipated in the forward-looking
statements could include, among other things, business disruption,
operational problems, financial loss, legal liability to third
parties and similar risks, any of which could have a material
adverse effect on Dow's or DuPont's consolidated financial
condition, results of operations, credit rating or liquidity.
Neither Dow nor DuPont assumes any obligation to publicly provide
revisions or updates to any forward-looking statements regarding
the proposed transaction and intended business separations, whether
as a result of new information, future developments or otherwise,
should circumstances change, except as otherwise required by
securities and other applicable laws. The company undertakes no
duty to publicly revise or update any forward-looking statements as
a result of future developments, or new information or otherwise,
should circumstances change, except as otherwise required by
securities and other applicable laws.
1 2011–2015 DuPont Pioneer research trials.
Qrome™ products are approved for cultivation in the United States and Canada and also have received import approval
in a number of importing countries. DuPont Pioneer continues
to pursue additional import approvals for Qrome™ products,
including in China, in accordance
with Excellence Through Stewardship Product Launch Guidance.
Agrisure® is a registered trademark of, and used
under license from, a Syngenta Group Company.
Agrisure® technology incorporated into these seeds is
commercialized under a license from Syngenta Crop Protection AG.
Herculex® XTRA insect protection technology by Dow
AgroSciences and Pioneer Hi-Bred. Herculex® and the HX
logo are registered trademarks of Dow AgroSciences LLC.
YieldGard®, the YieldGard Corn Borer design and Roundup
Ready® are registered trademarks used under license from
Monsanto Company. LibertyLink® and the Water Droplet
Design are trademarks of Bayer.
2 Data is based on average of 2016 comparisons made
across all major soybean growing areas of the United States through Nov. 29, 2016. Comparisons are against all
competitors in Pioneer IMPACT™ plots unless otherwise stated, and
within +/-03 RM of the competitive
brand. Product responses are variable and subject to any number of
environmental, disease and pest pressures. Individual results may
vary. Multi-year and multi-location data are a better predictor of
future performance. DO NOT USE THIS OR ANY OTHER DATA FROM A
LIMITED NUMBER OF TRIALS AS A SIGNIFICANT FACTOR IN PRODUCT
SELECTION.
DO NOT APPLY DICAMBA HERBICIDE IN-CROP TO SOYBEANS WITH
Roundup Ready 2 Xtend® technology unless you use a
dicamba herbicide product that is specifically labeled for that use
in the location where you intend to make the application. IT IS A
VIOLATION OF FEDERAL AND STATE LAW TO MAKE AN IN-CROP APPLICATION
OF ANY DICAMBA HERBICIDE PRODUCT ON SOYBEANS WITH Roundup Ready 2
Xtend® technology, OR ANY OTHER PESTICIDE APPLICATION,
UNLESS THE PRODUCT LABELING SPECIFICALLY AUTHORIZES THE USE.
Contact the U.S. EPA and your state pesticide regulatory agency
with any questions about the approval status of dicamba herbicide
products for in-crop use with soybeans with Roundup Ready 2
Xtend® technology.
ALWAYS READ AND FOLLOW PESTICIDE LABEL DIRECTIONS. Soybeans
with Roundup Ready 2 Xtend® technology contain genes
that confer tolerance to glyphosate and dicamba. Glyphosate
herbicides will kill crops that are not tolerant to glyphosate.
Dicamba will kill crops that are not tolerant to dicamba.
Roundup Ready 2 Xtend® is a trademark of Monsanto
Technology LLC used under license.
3 In trials conducted by Embrapa, (a group of
Independent Soy fungicide experts across Brazil) in the 2015/2016 season DuPont's
Vessarya™, on average over 30 different locations, was
the best performing product for the control of Asian soybean rust
with highest average yield of the 18 competitive treatments
tested.
DuPont™ Pyraxalt™ is not registered for use or sale in
the United States and other
countries. No offer for sale, sale or use of these products is
permitted prior to the issuance of the country level
registration.
DuPont™ Zorvec™ is not registered for use
or sale in the United States. No
offer for sale, sale or use of these products is permitted prior to
the issuance of the country level registration.
The DuPont Oval logo, DuPont™ and all products, unless otherwise
noted, denoted with ™, ℠ or ® are trademarks or registered
trademarks of E. I. du Pont de Nemours and Company or its
affiliates.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dupont-agriculture-executive-outlines-2017-growth-strategy-300416268.html
SOURCE DuPont